Cardiomyocytes treat the heart

iPSC-induced cardiomyocyte agents are a new technology for treating heart failure, myocardial infarction, and other diseases

View More →

Treatment of respiratory diseases

Evaluation services and model products based on organoid platforms

View More →

Assessment of biological effects on skin

Protecting skin health with precise prevention, repair, and supportive treatment

View More →